Cover Image
市場調查報告書

呼吸疾病用吸入器的全球市場:各產品、技術、醫療用途、地區

Global Respiratory Inhalers Market, by Product Type, Application, Technology, and Region - Trends and Analysis to 2025

出版商 Coherent Market Insights 商品編碼 521281
出版日期 內容資訊 英文 250 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
呼吸疾病用吸入器的全球市場:各產品、技術、醫療用途、地區 Global Respiratory Inhalers Market, by Product Type, Application, Technology, and Region - Trends and Analysis to 2025
出版日期: 2017年11月24日 內容資訊: 英文 250 Pages
簡介

本報告提供呼吸疾病用吸入器的全球市場調查,各產品、技術、醫療用途、地區的市場趨勢,市場規模的變化與預測,與前一年同期比較成長率,市場成長的影響因素及市場機會分析,競爭情形,以及主要企業的簡介等彙整。

第1章 調查目的、前提條件

第2章 市場範圍

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 推動因素
    • 課題
    • 機會
    • 法規環境
    • 產業趨勢
    • 流行病學
    • 合併、收購
    • 產品認證/銷售
  • 促銷、行銷

第4章 呼吸疾病用吸入器的全球市場:各產品

  • 簡介
    • 市場佔有率分析
    • 與前一年同期比較成長率分析
    • 各市場區隔趨勢
  • 定量噴霧吸入器(MDI)
    • 加壓式
    • 網膜式
    • 超音波式
  • 乾粉吸入劑
  • 噴霧器

第5章 呼吸疾病用吸入器的全球市場:各技術

  • 簡介
    • 市場佔有率分析
    • 與前一年同期比較成長率分析
    • 各市場區隔趨勢
  • 數位式吸入器
  • 手冊式吸入器

第6章 呼吸疾病用吸入器的全球市場:醫療各用途

  • 簡介
    • 市場佔有率分析
    • 與前一年同期比較成長率分析
    • 各市場區隔趨勢
  • 氣喘
  • 慢性阻塞性肺病(COPD)
  • 肺高血壓(PAH)
  • 其他

第7章 呼吸疾病用吸入器的全球市場:各地區

  • 簡介
    • 市場佔有率分析:各地區
    • 與前一年同期比較成長率分析:各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第8章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
  • 企業簡介
    • AstraZeneca
    • Beximco Pharmaceuticals Ltd.
    • Boehringer Ingelheim GmbH
    • Cipla Ltd.
    • GlaxoSmithKline plc
    • Tissuemed Ltd.
    • Koninklijke Philips N.V.
    • Merck & Co., Inc.
    • OMRON Healthcare Europe B.V.
    • PARI Medical Holding
    • Teva Pharmaceutical Industries Ltd
  • 分析師的見解

第9章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Chronic respiratory diseases are the group of chronic diseases which affect airways, lungs and the other parts of respiratory system. Chronic respiratory disease include asthma and respiratory allergies, Chronic Obstructive Pulmonary Disease (COPD), Occupational Lung Diseases, Sleep Apnea Syndrome and Pulmonary Hypertension. However 70% chronic respiratory disease are asthma and chronic obstructive pulmonary disease. In 2012, globally, 1 billion people are affected with chronic respiratory disease and account for 7% of all global deaths with addition 1.4 million lung cancer deaths annually. Tuberculosis is considered as one of the communicable lung disease and in 2012, 1.3 million people died of tuberculosis and 8.6 million new cases were yet to be treated.

The respiratory inhalers market is expected to gain steady traction in the foreseeable future as the product is available in various designs and can be used by any age group individual. Manufacturers are focused on reducing production costs and increasing profitability to sustain the market demand.

Market Dynamics

Factors such as rising prevalence of asthma, chronic obstructive respiratory disease and other respiratory diseases propel the respiratory inhalers market globally. However, drawbacks such as lack of a single effective inhaler devices, adverse effects and difficulties faced during drug inhalation, lack of skilled pulmonologist, higher price of inhaler devices are factors hindering respiratory inhalers market growth.

People suffering from respiratory disorders are now switching towards combinational therapies which is associated with benefits such as increased efficacy and easy reimbursement policies. Opting for combination therapies becomes tough for the individuals who have complex indications of respiratory disease. High preference of combination therapies such as triple combination therapy for chronic obstructive pulmonary disease (COPD) patients is expected to drive growth of the global respiratory inhaler market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the respiratory inhalers and is its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global respiratory inhalers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study include AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics

The global respiratory inhalers market report caters to various stakeholders in this industry, including investors, drug/product manufacturers, distributors and suppliers for respiratory inhalers, research and consulting firms, new entrants, and financial analysts

Various strategy matrices used in analyzing the respiratory inhalers market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Respiratory Inhalers Market, By Product Type:
  • Dry Powder Inhalers
  • Single Unit Dose
  • Multi Dose
  • Multi-Unit Dose
  • Metered Dose Inhalers
  • Nebulizers
  • Compressed
  • Mesh
  • Ultrasonic
  • Global Respiratory Inhalers Market, By Application:
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis
  • Global Respiratory Inhalers Market, By Technology:
  • Digital
  • Manual
  • Global Respiratory Inhalers Market, By Geography:
  • North America,
  • By Product Type:
  • Dry Powder Inhalers
  • Single Unit Dose
  • Multi Dose
  • Multi-Unit Dose
  • Metered Dose Inhalers
  • Nebulizers
  • Compressed
  • Mesh
  • Ultrasonic
  • By Application:
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis
  • By Technology
  • Digital
  • Manual
  • By Country
  • U.S.
  • Canada
  • Europe
  • By Product Type:
  • Dry Powder Inhalers
  • Single Unit Dose
  • Multi Dose
  • Multi-Unit Dose
  • Metered Dose Inhalers
  • Nebulizers
  • Compressed
  • Mesh
  • Ultrasonic
  • By Application:
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis
  • By Technology
  • Digital
  • Manual
  • By Country
  • U.K.
  • Germany
  • Italy
  • France
  • Russia
  • Spain
  • Rest of Europe
  • Asia Pacific
  • By Product Type:
  • Dry Powder Inhalers
  • Single Unit Dose
  • Multi Dose
  • Multi-Unit Dose
  • Metered Dose Inhalers
  • Nebulizers
  • Compressed
  • Mesh
  • Ultrasonic
  • By Application:
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis
  • By Technology
  • Digital
  • Manual
  • By Country
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Product Type:
  • Dry Powder Inhalers
  • Single Unit Dose
  • Multi Dose
  • Multi-Unit Dose
  • Metered Dose Inhalers
  • Nebulizers
  • Compressed
  • Mesh
  • Ultrasonic
  • By Application:
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis
  • By Technology
  • Digital
  • Manual
  • By Country
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • By Product Type:
  • Dry Powder Inhalers
  • Single Unit Dose
  • Multi Dose
  • Multi-Unit Dose
  • Metered Dose Inhalers
  • Nebulizers
  • Compressed
  • Mesh
  • Ultrasonic
  • By Application:
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis
  • By Technology
  • Digital
  • Manual
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type:
  • Dry Powder Inhalers
  • Single Unit Dose
  • Multi Dose
  • Multi-Unit Dose
  • Metered Dose Inhalers
  • Nebulizers
  • Compressed
  • Mesh
  • Ultrasonic
  • By Application:
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis
  • By Technology
  • Digital
  • Manual
  • By Country
  • North Africa
  • Central Africa
  • South Africa
  • Company Profiles
  • AstraZeneca Plc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Future Plans
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline Plc.
  • Koninklijke Philips N.V.
  • Merck & Co. Inc.
  • Omron Healthcare Europe B.V.
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.
  • H&T PRESSPART
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet By Devices
    • Market Snippet By Technology
    • Market Snippet By Therapeutic Application
    • Market Snippet By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Challenges
    • Market Opportunities
  • Regulatory Scenario
  • Industry Trend
  • Epidemiology
  • Merger and Acquisitions
  • New Product Approvals/Launch
  • Promotion and Marketing Initiatives

4. Global Respiratory Inhalers Market, By Devices, 2015 - 2025 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2025 (%)
    • Y-O-Y Growth Analysis, 2015 - 2025
    • Segment Trends
  • Nebulizers
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Compressed
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Mesh
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Ultrasonic
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Dry Powder Inhaler
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Single Unit Dose Inhaler
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Multi Dose Inhaler
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Multi-Unit Dose Inhaler
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Metered Dose Inhaler
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)

5. Global Respiratory Inhalers Market, By Technology, 2015 - 2025 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2025 (%)
    • Y-O-Y Growth Analysis, 2015 - 2025
    • Segment Trends
  • Digital
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Manual
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)

6. Global Respiratory Inhalers Market, By Therapeutic Application, 2015 - 2025 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2025 (%)
    • Y-O-Y Growth Analysis, 2015 - 2025
    • Segment Trends
  • Asthma
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Chronic Obstructive Pulmonary Disease
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Pulmonary Arterial Hypertension
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Cystic Fibrosis
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)

7. Global Respiratory Inhalers Market, By Regions, 2015 - 2025 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2017 and 2025 (%)
    • Y-O-Y Growth Analysis, For Regions, 2015 - 2025
  • North America
    • Regional Trends
    • Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
    • U.S.
  • Europe
    • Regional Trends
    • Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Regional Trends
    • Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Regional Trends
    • Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East
    • Regional Trends
    • Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Regional Trends
    • Market Size and Forecast, By Devices, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2015 - 2025 (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • AstraZeneca plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Beximco Pharmaceuticals Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Cipla Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Koninklijke Philips N.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • OMRON Healthcare Europe B.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • PARI Medical Holding
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Teva Pharmaceutical Industries Ltd
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • H&T PRESSPART
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact

Browse 25 market data tables and 35 figures on "Respiratory Inhalers Market - Global forecast to 2025"

Back to Top